Anesthetic Management of a Patient with Amyotrophic Lateral Sclerosis undergoing Percutaneous Endoscopic Gastrostomy

Main Article Content

Tanatporn Pisitpitayasaree
Piraya Akaravinek


This is a case of a 62-year-old female with amyotrophic lateral sclerosis (ALS) and bulbar involvement. The patient was scheduled for percutaneous endoscopic gastrostomy under general anesthesia. The TOF stimulation was used to monitor neuromuscular blockade from the beginning of the induction until extubating process. General anesthesia was induced by intravenous administration of propofol and was intubated with rocuronium. General anesthesia was maintained by sevoflurane. Pain control with local infiltration of 0.5% bupivacaine at the surgical site without an intravenous opioid. The patient emerged from general anesthesia smoothly and was extubated after an administration of sugammadex without any complications. This case report showed that rocuronium and sugammadex could be used safely in these patients; however, neuromuscular monitoring and clinical correlation should be performed to determine the muscle power to ensure the extubating process, and further research is needed to determine the appropriate dose of rocuronium and sugammadex for ALS patients.

Article Details

Original articles


Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81(4):385-90.

Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, et al. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. MMWR Suppl. 2014;63(7):1-14.

Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162-72.

Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171.

Prabhakar A, Owen CP, Kaye AD. Anesthetic management of the patient with amyotrophic lateral sclerosis. J Anesth. 2013;27(6):909-18.

Soriani MH, Desnuelle C. Epidemiology of amyotrophic lateral sclerosis. Rev Neurol (Paris). 2009;165(8-9):627-40.

Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1-2):13-21.

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1227-33.

Hoeper AM, Barbara DW, Watson JC, Sprung J, Weingarten TN. Amyotrophic lateral sclerosis and anesthesia: a case series and review of the literature. J Anesth. 2019;33(2):257-65.

Kelsaka E, Karakaya D, Zengin EC. Use of sugammadex in a patient with amyotrophic lateral sclerosis. Med Princ Pract. 2013;22(3):304-6.

Chang YJ, Jung WS, Son WR, Jo YY. Discordance between train-of-four response and clinical symptoms in a patient with amyotrophic lateral sclerosis. Acta Med Okayama. 2014;68(2):125-7.